Tender Spots of Pharma Industry III – Blog Post #388 by Asrar Qureshi
Tender Spots of Pharma Industry III – Blog Post #388 by Asrar Qureshi Dear Colleagues! This is Pharma Veterans Blog Post #388. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here . Reference Countries – DRAP considers reference countries from three angles. One, there is a list of countries from where prices of similar drugs are taken, and a basket price is determined which becomes the basis for price fixation in Pakistan. It was mentioned in the previous blog also. Two, all new applications for registration are checked against availability in the SRA (Stringent Regulatory Authority) countries. These include US, EU, UK, Japan and Australia. If a drug or combination or dosage form is not available in SRA countries, the DRAP rejects...